Hyperhydration using different hydration agents does not affect the haematological markers of the athlete biological passport in euhydrated volunteers

References

• Athanasiadou, I., Dokoumetzidis, A., Voss, C. S., El Saftawy, W., Al Maadheed, M., Valsami, G., & Georgakopoulos, C. (2019). Hyperhydration effect on pharmacokinetic parameters and detection sensitivity of recombinant human erythropoietin in urine and serum doping control analysis of males. Journal of Pharmaceutical Sciences, 108(6), 2162–2172. https://doi.org/10.1016/j.xphs.2019.01.017
   PubMed Web of Science ®Google Scholar
• Bejder, J., Hoffmann, M. F., Ashenden, M., Nordsborg, N. B., Karstoft, K., & Mørkeberg, J. (2016). Acute hyperhydration reduces athlete biological passport OFF-hr score. Scandinavian Journal of Medicine & Science in Sports, 26(3), 338–347. https://doi.org/10.1111/sms.12438
   PubMed Web of Science ®Google Scholar
• Freund, B. J., Montain, S. J., Young, A. J., Sawka, M. N., DeLuca, J. P., Pandolf, K. B., & Valeri, C. R. (1995). Glycerol hyperhydration: Hormonal, renal, and vascular fluid responses. Journal of Applied Physiology, 79(6), 2069–2077. https://doi.org/10.1152/jappl.1995.79.6.2069
   PubMed Web of Science ®Google Scholar
• Kimura, T., Abe, K., Ota, K., Omata, K., Shoji, M., Kudo, K., Matsui, K., Inoue, M., Yasujima, M., & Yoshinaga, K. (1986). Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans. The Journal of Clinical Endocrinology & Metabolism, 62(5), 1003–1010. https://doi.org/10.1210/jcem-62-5-1003
   PubMed Web of Science ®Google Scholar
• Lombardi, G. (2013). Reply to Gore et al.: Plasma volume shift during multiday racing. Clinical Chemistry and Laboratory Medicine, 51(6), 111–112. https://doi.org/10.1515/cclm-2012-0887
   Web of Science ®Google Scholar
• Martin, L., Ashenden, M., Bejder, J., Hoffmann, M., Nordsborg, N., Karstoft, K., Morkeberg, J., Sharpe, K., Lasne, F., & Marchand, A. (2016). New insights for identification of doping with rHuEPO microdoses after high hydration. Drug Testing and Analysis, 8(11–12), 1119‒1130. https://doi.org/10.1002/dta.2004
   Web of Science ®Google Scholar
• Neorecormon® DS 180625. (2018). Roche products limited. Retrieved October 11, 2018, from. http://medsafe.govt.nz/profs/Datasheet/n/Neorecormoninj.pdf.
   Google Scholar
• Racinais, S., Mohr, M., Buchheit, M., Voss, S. C., Gaoua, N., Grantham, J., & Nybo, L. (2012). Individual responses to short-term heat acclimatisation as predictors of football performance in a hot, dry environment. British Journal of Sports Medicine, 46(11), 810–815. https://doi.org/10.1136/bjsports-2012-091227
   PubMed Web of Science ®Google Scholar
• Rasmussen, P., Siebenmann, C., Diaz, V., & Lundby, C. (0000). Red cell volume expansion at altitude: A meta-analysis and monte carlo simulation. Medicine & Science in Sports & Exercise, 45(9), 1767–1772. https://doi.org/10.1249/MSS.0b013e31829047e5
   PubMed Web of Science ®Google Scholar
• Robinson, N., Sottas, P. E., Mangin, P., & Saugy, M. (2007). Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes. Haematologica, 92(8), 1143–1144. https://doi.org/10.3324/haematol.11182
   PubMed Web of Science ®Google Scholar
• Sadowska, A., Świderski, F., Rakowska, R., Waszkiewicz-Robak, B., Żebrowska-Krasuska, M., & Dybkowska, E. (2017). Beverage osmolality as a marker for maintaining appropriate body hydration. Roczniki Panstwowego Zakladu Higieny, 68(2), 167–173. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28646834
   PubMedGoogle Scholar
• Salmonson, T., Danielson, B. G., & Wikström, B. (1990). The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. British Journal of Clinical Pharmacology, 29(6), 709‒713. https://doi.org/10.1111/j.1365-2125.1990.tb03692.x
   PubMed Web of Science ®Google Scholar
• Siebenmann, C., Hug, M., Keiser, S., Müller, A., van Lieshout, J., Rasmussen, P., & Lundby, C. (2013). Hypovolemia explains the reduced stroke volume at altitude. Physiological Reports, 1(5), 1–9. https://doi.org/10.1002/phy2.94
   Google Scholar
• Simoni, R. E., Scalco, F. B., De Oliveira, M. L. C., & Neto, F. R. A. (2011). Plasma volume expanders: Use in medicine and detecting misuse in sports. Bioanalysis, 3(2), 215–226. https://doi.org/10.4155/bio.10.181
   PubMed Web of Science ®Google Scholar
• Sottas, P. E., Robinson, N., Giraud, S., Taroni, F., Kamber, M., Mangin, P., & Saugy, M. (2006). Statistical classification of abnormal blood profiles in athletes. The International Journal of Biostatistics, 2(1), 1–21. https://doi.org/10.2202/1557-4679.1011
   Google Scholar
• VeloNation Press. Retrieved February 1, 2020, from. http://www.velonation.com/News/ID/3948/Thomas-Frei-used-micro-doses-and-water-to-avoid-EPO-detection.aspx
   Google Scholar
• Voss, S. C., Alsayrafi, M., Bourdon, P. C., Klodt, F., Nonis, D., Hopkins, W. G., & Schumacher, Y. O. (2014). Variability of serum markers of erythropoiesis during 6 days of racing in highly trained cyclists. International Journal of Sports medicine, 35(2), 89–94. https://doi.org/10.1055/s-0033-1345177
   PubMed Web of Science ®Google Scholar
• World Anti-Doping Agency. (2016). ISTI blood sample collection guidelines. Version 5.0. Retrieved February 1, 2020, from. https://www.wada-ama.org/sites/default/files/resources/files/guidelines_blood_sample_collection_v5_sept_2016.pdf
   Google Scholar
• World Anti-Doping Agency. (2019). ISTI, ISL athlete biological passport operating guidelines. Version 7.1. Retrieved February 1, 2020, from. https://www.wada-ama.org/sites/default/files/resources/files/guidelines_abp_v71.pdf
   Google Scholar
• World Anti-Doping Agency. World anti-doping code: The 2020 prohibited list. Available at: https://www.wada-ama.org/sites/default/files/wada_2020_english_prohibited_list_0.pdf (accessed February 1st, 2020a)
   Google Scholar
• World Anti-Doping Agency. ISTI Urine Sample Collection Guidelines (ver. 6.0). Available at: https://www.wada-ama.org/sites/default/files/resources/files/wada_guidelines_urine_sample_collection_2014_v1.0_en.pdf (accessed February 1st, 2020b).
   Google Scholar
• World Anti-Doping Agency. WADA Technical Document - TD2014EPO (ver. 1.0): Harmonization of analysis and reporting of erythropoiesis stimulating agents (ESAs) by electrophoretic techniques, 2014. Available at https://www.wada-ama.org/sites/default/files/resources/files/WADA-TD2014EPO-v1-Harmonization-of-Analysis-and-Reporting-of-ESAs-by-Electrophoretic-Techniques-EN.pdf. (accessed February 1st, 2020).
   Google Scholar
• World Anti-Doping Agency. WADA Technical Document – TD2017BAR (ver. 6.0): Blood Analytical Requirements for the Athlete Biological Passport, 2017. Available at: https://www.wada-ama.org/sites/default/files/resources/files/wada_td2017bar_blood_analysis_requirements_en.pdf (accessed February 1st, 2020).
   Google Scholar
• World Anti-Doping Agency. WADA Technical Document – TD2019BAR (ver. 1.0): Blood Analytical Requirements for the Athlete Biological Passport, 2019a. Available at: https://www.wada-ama.org/sites/default/files/resources/files/td2019bar_0.pdf (accessed February 1 2020).
   Google Scholar
• World Anti-Doping Agency. WADA Technical Document – TD2019APMU (ver. 1.0): Athlete Passport Management Unit. Requirements and Procedures, 2019b. Available at: https://www.wada-ama.org/sites/default/files/resources/files/td2019apmu_final2.pdf (accessed February 1st, 2020).
   Google Scholar